Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Uenishi
Cytokeratin-19 Fragments in Serum (CYFRA 21-1) as a Marker in Primary Liver Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Decreased Levels of Serum Cytokeratin 19 Fragment CYFRA 21-1 Predict Objective Response to Chemotherapy in Patients With Non-Small Cell Lung Cancer
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Clinical Impact of CYFRA 21 – 1 as a Tumor Marker for Regional and Distant Tumor Control in Advanced Oropharyngeal Cancer
Correction: Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-Cyfra 21-1 Autoantibody Immune Complex for Detection of Early Stage Lung Cancer
Chemical Communications
Surfaces
Alloys
Materials Chemistry
Coatings
Metals
Optical
Magnetic Materials
Films
Catalysis
Chemistry
Electronic
Composites
Ceramics
Preoperative CYFRA 21-1 Level as a Prognostic Indicator in Resected Nonsmall Cell Lung Cancer
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using CYFRA 21-1
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Fine-Needle Aspirates CYFRA 21-1 Is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients
PLoS ONE
Multidisciplinary
CYFRA 21‐1 and CEA Combination Assay in EMPD
British Journal of Dermatology
Dermatology
Medicine
The Role of Serum Cytokeratin 19 Fragment in Transarterial Infusion Against Invasive Bladder Cancer
Open Journal of Urology
S100β as a Serum Marker in Endocrine Resistant Breast Cancer
BMC Medicine
Medicine